MCK · News · 20260804N

Revenue Performance and Mix

MCKESSON CORP · 2026-08-04 · Importance 34 · Surprise 32

McKesson reported fiscal Q1 2027 revenue of $105.38 billion, up 7.7% year over year and ahead of consensus estimates by 0.95%. Growth was driven by the U.S. Pharmaceutical business, oncology services and specialty medicines, although pricing dynamics moderated revenue momentum. Medical-Surgical Solutions revenue increased 4% year over year to $2.8 billion. The results reflected stronger prescription volumes and demand for specialty pharmaceuticals.

Key facts